CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the phase III QWINT development program found. In QWINT-1, there was a similar ...
Share on Pinterest Eli Lilly’s once-weekly insulin injection is as effective as daily shots for managing blood sugar in diabetes, new data shows. Scott Olson/Getty Images New research offers an ...
Results from a very small study suggest that a combination of the diabetes drug Ozempic and an innovative new intestinal procedure could help erase the need for insulin in folks with Type 2 diabetes.
Medpage Today on MSN
Type 2 Diabetes Patients Also Reap Benefits of Automated Insulin Delivery
An automated insulin delivery (AID) system boosted glycemic control in insulin-treated adults with type 2 diabetes using ...
Treatment with once-weekly IcoSema demonstrated noninferiority in HbA1c reduction at week 52 compared with insulin glargine and aspart. Treatment with once-weekly IcoSema, a fixed-ratio combination of ...
COMBINE 3 phase 3a trial successfully completed with once-weekly IcoSema demonstrating non-inferior reduction in HbA1c versus daily basal-bolus treatment (insulin glargine U100 and insulin aspart) in ...
A groundbreaking treatment for type 2 diabetes has emerged, offering hope to millions of patients worldwide. This innovative approach combines a novel procedure with medication, potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback